Close Menu

Seems many are speaking up about the attempt of New York and California to restrict personal genetic testing. Over at The Personal Genome, Jason Bobe calls the cease-and-desist letters a form of "biocensorship," while an editorial in Nature Biotechnology wonders how personalized medicine is to advance if the current state of medicine isn't changed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.